Page last updated: 2024-08-16

timolol and debrisoquin

timolol has been researched along with debrisoquin in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19908 (66.67)18.7374
1990's2 (16.67)18.2507
2000's1 (8.33)29.6817
2010's1 (8.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Huupponen, R; Iisalo, E; Kaila, T; Lahdes, K; Salminen, L1
al-Sereiti, MR; Edeki, T; Lledo, P; Turner, P1
Brawn, LA; Jackson, PR; Lennard, MS; Lewis, RV; Ramsay, LE; Tucker, GT; Woods, HF1
Huupponen, R; Iisalo, E; Kaila, T; Lindberg, R; Salminen, L; Toivari, HR1
Jackson, PR; Lennard, MS; Lewis, RV; Ramsay, LE; Tucker, GT; Woods, HF1
Fleming, JJ; McBurney, A; McGourty, JC; Silas, JH; Ward, JW1
Smith, RL1
Lennard, MS; Silas, JH; Tucker, GT; Woods, HF1
Lennard, MS; Parkin, S1
Hayashi, M; Takase, M1

Other Studies

12 other study(ies) available for timolol and debrisoquin

ArticleYear
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Systemic absorption of ocular timolol in poor and extensive metabolizers of debrisoquine.
    Journal of ocular pharmacology, 1991,Summer, Volume: 7, Issue:2

    Topics: Absorption; Adult; Blood; Debrisoquin; Female; Humans; Intraocular Pressure; Male; Ophthalmic Solutions; Polymorphism, Genetic; Radioligand Assay; Timolol

1991
The effects of timolol on intraocular pressure and exercise heart rate in poor and extensive debrisoquine metabolizers.
    International journal of clinical pharmacology research, 1990, Volume: 10, Issue:6

    Topics: Adult; Debrisoquin; Electrocardiography; Exercise; Female; Heart Rate; Humans; Intraocular Pressure; Male; Phenotype; Timolol

1990
Timolol metabolism and debrisoquine oxidation polymorphism: a population study.
    British journal of clinical pharmacology, 1989, Volume: 27, Issue:4

    Topics: Adult; Debrisoquin; Female; Humans; Isoquinolines; Male; Middle Aged; Oxidation-Reduction; Phenotype; Timolol

1989
Prevalence of debrisoquine oxidation phenotypes in glaucoma patients.
    International ophthalmology, 1989, Volume: 13, Issue:1-2

    Topics: Cross-Sectional Studies; Debrisoquin; Glaucoma; Glaucoma, Open-Angle; Humans; Isoquinolines; Oxidation-Reduction; Phenotype; Polymorphism, Genetic; Timolol

1989
Timolol and atenolol: relationships between oxidation phenotype, pharmacokinetics and pharmacodynamics.
    British journal of clinical pharmacology, 1985, Volume: 19, Issue:3

    Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Chromatography, High Pressure Liquid; Debrisoquin; Heart Rate; Humans; Kinetics; Male; Oxidation-Reduction; Phenotype; Physical Exertion; Spectrophotometry, Ultraviolet; Timolol

1985
Pharmacokinetics and beta-blocking effects of timolol in poor and extensive metabolizers of debrisoquin.
    Clinical pharmacology and therapeutics, 1985, Volume: 38, Issue:4

    Topics: Absorption; Administration, Oral; Adrenergic beta-Antagonists; Adult; Biotransformation; Chromatography, High Pressure Liquid; Debrisoquin; Heart Rate; Humans; Isoquinolines; Kinetics; Male; Middle Aged; Phenotype; Physical Exertion; Timolol

1985
Polymorphic metabolism of the beta-adrenoreceptor blocking drugs and its clinical relevance.
    European journal of clinical pharmacology, 1985, Volume: 28 Suppl

    Topics: Adrenergic beta-Antagonists; Animals; Biological Availability; Blood Pressure; Debrisoquin; Ethanolamines; Glucuronates; Humans; Hydroxylation; Kinetics; Lipids; Metoprolol; Phenotype; Polymorphism, Genetic; Propranolol; Solubility; Structure-Activity Relationship; Timolol

1985
Debrisoquine polymorphism and the metabolism and action of metoprolol, timolol, propranolol and atenolol.
    Xenobiotica; the fate of foreign compounds in biological systems, 1986, Volume: 16, Issue:5

    Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Debrisoquin; Genetic Variation; Humans; Hypertension; Isoquinolines; Kinetics; Male; Metoprolol; Oxidation-Reduction; Phenotype; Polymorphism, Genetic; Propranolol; Structure-Activity Relationship; Timolol

1986
Timolol determination in plasma and urine by high-performance liquid chromatography with ultraviolet detection.
    Journal of chromatography, 1985, Feb-27, Volume: 338, Issue:1

    Topics: Chromatography, High Pressure Liquid; Debrisoquin; Humans; Phenotype; Spectrophotometry, Ultraviolet; Timolol

1985
[A population study of the poor metabolizers of the debrisoquine type in Japan].
    Nippon Ganka Gakkai zasshi, 1985, Volume: 89, Issue:8

    Topics: Administration, Oral; Asian People; Debrisoquin; Humans; Isoquinolines; Japan; Male; Propranolol; Timolol

1985